Korean firms shy of R&D
Published: 2011-09-29 06:59:00
Updated: 2011-09-29 06:59:00
Korean drug firms are showing a negative attitude towards research and development (R&D) due to the government’s plan to cut drug prices by an average of 17 percent starting next year, according to Rep. Choi Young-hee of the main opposition Democratic Party who commissioned the survey with the Ko...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.